) --

Neogen Corporation



) hit a new 52-week high Thursday as it is currently trading at $43.29, above its previous 52-week high of $43.14 with 154,599 shares traded as of 2:52 p.m. ET. Average volume has been 103,400 shares over the past 30 days.

Neogen has a market cap of $934.3 million and is part of the

health care

sector and


industry. Shares are up 0.5% year to date as of the close of trading on Wednesday.

Neogen Corporation, through its subsidiaries, engages in the development, manufacture, and sale of various products for food safety testing and animal health applications. It operates in two segments, Food Safety and Animal Safety. The company has a P/E ratio of 44.3, above the average drugs industry P/E ratio of 43.8 and above the S&P 500 P/E ratio of 17.7.

  • Practice your NEOG trading strategies and win cash in our stock game.

TheStreet Ratings rates Neogen as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full

Neogen Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center